74209-51-1

Basic information

• Product Name: Ethanone, 1-(3-pyridinyl)-, O-[(4-methylphenyl)sulfonyl]oxime
• Synonyms: 1-(3-pyridinyl)-ethanone O-[(4-methylphenyl)sulphonyl]-oxime
• CAS NO: 74209-51-1
• Molecular Formula: C14H14N2O3S
• Molecular Weight: 290.343
• Mol File: 74209-51-1.mol

Chemical Properties

• Melting Point: 77-79 °C(Solv: ethanol (64-17-5); water (7732-18-5))
• Boiling Point: 441.9±47.0 °C(Predicted)
• Density: 1.23±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Ethanone, 1-(3-pyridinyl)-, O-[(4-methylphenyl)sulfonyl]oxime(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(3-pyridinyl)-, O-[(4-methylphenyl)sulfonyl]oxime(74209-51-1)
• EPA Substance Registry System: Ethanone, 1-(3-pyridinyl)-, O-[(4-methylphenyl)sulfonyl]oxime(74209-51-1)

Safety Data

• Hazardous Substances Data: 74209-51-1(Hazardous Substances Data)

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 350-03-8 methyl-3-pyridylketone 
• 5973-83-1 1-(pyridin-3-yl)ethan-1-one oxime 
• 106881-77-0 (E)-1-(pyridin-3-yl)ethanone oxime 

Downstream Products

• 93103-29-8 4-(pyridin-3-yl)-1H-imidazole-2(3H)-thione 
• 51746-85-1 3-(1H-imidazol-4-yl)pyridine 
• 1233855-18-9 N-cyclohexyl-N-methyl-4-(pyridin-3-yl)-1H-imidazole-1-carboxamide 
• 1233855-46-3 3-(1-(cyclohexyl(methyl)carbamoyl)-1H-imidazol-4-yl)pyridine 1-oxide 
• 1356960-88-7 C₁₅H₁₁N₃O₂ 
• 1356960-60-5 N-benzyl-N-methyl-4-(pyridin-3-yl)-1H-imidazole-1-carboxamide 
• 51746-82-8 2-amino-1-pyridin-3-yl-ethanone dihydrochloride salt 
• 173838-67-0 4-(3-pyridyl)-1H-imidazol-1-butanamide phthalimide 
• 93103-29-8 4-Pyridin-3-yl-1H-imidazole-2-thiol 
• 51941-15-2 3-(α-aminoacetyl)pyridine 
• 254430-68-7 3-(2H-azirin-3-yl)pyridine 
• 107445-24-9 2,2-diethoxy-2-(3-pyridyl)ethylamine dihydrochloride 

Relevant articles and documents

Synthesis and Antibacterial Activity of Novel 4″-O-desosaminyl clarithromycin derivatives with 11, 12-arylalkyl side chains

A series of novel 4″-O-desosaminyl clarithromycin derivatives with 11, 12-arylalkyl side chains was synthesized by coupling 6-deoxy-desosamine donors (18, 19) with 4″-OH of compounds 5a–c. The activities of the target compounds were tested against a series of macrolide-sensitive and macrolide-resistant pathogens. Some of them showed activities against macrolide sensitive and resistant pathogens, and compounds 21d and 21e displayed significant improvement of activities against resistant pathogens.

PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS

A process for preparing a substituted urea compound of Formula II or Formula I, or a pharmaceutically acceptable salt or ester thereof, Formula II, Formula I the process comprising the reaction of an intermediate of Formula II' or Formula 1', Formula II',

Efficient synthesis of 2-imidazol-2-ylacetates

A simple method of synthesizing various 2-imidazol-2-ylacetates is described. Condensation of α-aminoketals with imidates, followed by cyclization in refluxing 4 M-HCl/Dioxane, yielded 2-imidazol-2-ylacetates under one-pot and mild reaction conditions.

Process for preparing pyridine-substituted amino ketal derivatives

The present invention relates to an efficient process for preparing derivatives of 1-(pyridinyl)-1,1-dialkoxy-2-aminoethane of the formula (I), with which compounds of the formula (I) can be prepared in high purity and yield and in the form of the free ba

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof

γ-Hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamide compounds are inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. These compounds are effective against HIV viral mutants which are resistant to HIV protease inhibitors currently used for treating AIDS and HIV infection.